by Northwestern University Credit: Pixabay/CC0 Public Domain A major impediment to treating the deadly brain cancer glioblastoma has been that the most potent chemotherapy can’t permeate the blood-brain barrier to reach the aggressive brain tumor. But now Northwestern Medicine scientists report results of the first in-human clinical trial in which they used a novel, skull-implantable ultrasound...
A University of Alberta research lab has helped identify a genetic variant that increases the risk of hearing loss in children with cancer who are treated with the widely used drug cisplatin. Amit Bhavsar, assistant professor in the Department of Medical Microbiology & Immunology and Canada Research Chair in Functional Genomic Medicine, led the U of A...
Researchers at Children’s Cancer Institute have discovered what could prove a new and improved way to treat the poor-prognosis blood cancer, acute myeloid leukaemia or AML Researchers at Children’s Cancer Institute have discovered what could prove a new and improved way to treat the poor-prognosis blood cancer, acute myeloid leukaemia or AML. Unlike acute lymphoblastic...
By Rachel Schraer Health reporter A drug that could stop cancer cells repairing themselves has shown early signs of working. More than half of the 40 patients given berzosertib had the growth of their tumours halted. Berzosertib was even more effective when given alongside chemotherapy, the trial run by the Institute of Cancer Research (ICR)...
Finger joint pain may affect a person’s everyday activities and may have several different causes. Some people may experience finger joint pain that worsens when they move or press on the finger. Others may have persistent finger joint pain that does not improve with rest or over-the-counter (OTC) treatment. This article discusses the causes, symptoms,...
In a new study, an alternative treatment regimen that is less toxic than standard dose-intensive chemotherapy was found to be highly effective for adults with Burkitt lymphoma across all age groups and independent of HIV status. In addition to being better tolerated, the regimen, called dose-adjusted (DA) EPOCH-R, is already an option for diffuse large...
by The Mount Sinai Hospital A clinical trial led by Mount Sinai researchers has showed for the first time that combining chemotherapy and immunotherapy can slow down metastatic bladder cancer. The trial also showed that immunotherapy alone may be an option for a subset of patients with metastatic bladder cancer if their tumor expresses a...
Bacteria could be inhibiting the efficacy of traditional cancer treatments Many great scientific discoveries have arisen out of laboratory accidents, from the mistake that led to penicillin, to revelations of LSD’s psychedelic properties after Albert Hoffman unexpectedly absorbed a dose through his fingertips in 1943. The latest serendipitous discovery comes from a cross-contamination accident that...
